LicianPro

CNTX stock

Context Therapeutics Inc (CNTX) short interest & short volume · 4.3M shares short

Context Therapeutics Inc official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.

What changed

CNTX short interest fell 9.2% to 4.3M shares in the Oct 15, 2026 report (5.1 days to cover). Daily short volume averaged 51.6% of volume over the last 20 sessions, up from 50.2% the 20 sessions before, the 96th percentile of its own 20-day averages since Sep 23, 2025.

Short interest

Official, twice monthly · settled Oct 15, 2026

Shares short
4.3M
prior 4.7M
% of float
—
no float on file
Days to cover
5.1
avg vol 841K
Change vs prior report
-9.2%

6 reports

The last 24 reports (about a year) with Lician Pro.Start 3-day trial — $149/yr

Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.

Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026

Daily short volume

Share of each day's volume sold short · FINRA Reg SHO

Latest (Nov 2)
44.0%
377K of 856K
20-day average
51.6%
prior 50.2%
Percentile vs own history
96th
233 periods since 2025

Loading prices…

Short volumeRest of the day's volume

Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026

Short squeeze score (model)

Price since settlement: -19.5%

Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.

CNTX's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr

Market-wide: most shorted stocks, biggest changes and unusual short volume · CNTX overview

Last 10 sessions · daily short volume · FINRA Reg SHO
DateShortTotalShort % of volume
2026-11-02376,502855,80644.0%
2026-10-30269,345555,93148.5%
2026-10-29348,648596,23458.5%
2026-10-28454,375706,97664.3%
2026-10-27202,6111,147,51317.7%
2026-10-26175,178262,28466.8%
2026-10-23201,063609,96233.0%
2026-10-22253,876719,83635.3%
2026-10-21409,166672,45460.9%
2026-10-20282,497487,57857.9%

Healthcare peers with similar quant ratings

CNTX among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works

CNTX short interest FAQ

What is CNTX's short interest?

Context Therapeutics Inc (CNTX) had 4.3M shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report.

How many days to cover does CNTX have?

5.1 days: 4.3M shares short divided by an average daily volume of 841K for the Oct 15, 2026 period.

Is CNTX short interest rising or falling?

CNTX short interest fell (-9.2%) from 4.7M to 4.3M shares in the Oct 15, 2026 report.

Is CNTX a short squeeze candidate?

Lician's squeeze watch scores CNTX 13 out of 100 (low) from the Oct 15, 2026 report: days to cover 12.7/25, change in short interest vs prior report 0/15, price change since settlement date 0/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.

What share of CNTX daily volume is sold short?

51.6% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 96th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.

What was CNTX's latest FINRA short volume?

On Nov 2, 2026, cached FINRA short volume for Context Therapeutics Inc (CNTX) was 376,502 shares, 44.0% of 855,806 total volume.

How many CNTX short-volume sessions are listed on this page?

This page lists 10 cached FINRA short-volume sessions for Context Therapeutics Inc (CNTX), from Oct 20, 2026 through Nov 2, 2026.

How did CNTX short volume percent change from the prior cached session?

Cached FINRA short volume for Context Therapeutics Inc (CNTX) moved from 48.5% on Oct 30, 2026 to 44.0% on Nov 2, 2026, down 4.5 percentage points.

Not investment advice. Figures as filed or reported, not a live feed.